Robert K Hills

20PUBLICATIONS
20CO-AUTHORS
Nanotoxicology, health and safetyHaematological tumoursEpidemiological modellingCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 08, 2025
Seeing something new or with new eyes?

Robert K Hills

|Nov 28, 2023
A randomised evaluation of low-dose cytosine arabinoside plus lenalidomide versus single-agent low-dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI-1 trial.

Mhairi Copland, Cono Ariti, Ian F Thomas

|Aug 23, 2023
Acute myeloid leukaemia in Afghanistan: Understanding an unfamiliar landscape.

Robert K Hills

|Apr 03, 2023
What drives CAR-T emergent cytopenia?

Robert K Hills

|Apr 07, 2022
A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial.

Nigel H Russell, Robert K Hills, Lars Kjeldsen

|Dec 14, 2021
Treatment intensification with FLAG-Ida may improve disease control in younger patients with secondary acute myeloid leukaemia: long-term follow up of the MRC AML15 trial.

Nigel Russell, Robert Hills, Lars Kjeldsen

Pageof 4

Frequent Collaborators

4 joint publications

Nigel Russell

3 joint publications

Rosemary E Gale

2 joint publications

Mike Dennis

2 joint publications

David C Linch